查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球胎儿监护市场：按产品（超声波,胎儿监护仪,遥测设备,胎儿电极）,便携性,技术（侵入/非侵入式）,应用（产前,分娩）,用户,地区预测 (2027)
市场调查报告书
商品编码
1191020

全球胎儿监护市场：按产品（超声波,胎儿监护仪,遥测设备,胎儿电极）,便携性,技术（侵入/非侵入式）,应用（产前,分娩）,用户,地区预测 (2027)

Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region -Global Forecast -2027
出版日期: | 出版商: MarketsandMarkets | 英文 238 Pages | 订单完成后即时交付

价格
简介目录

全球胎儿监护市场规模预计将从 2022 年的 37 亿美元增长到 2027 年的 52 亿美元，预测期内復合年增长率为 7.3%。

市场的主要驱动力包括胎儿监护产品的技术进步和妇科诊所数量的增加。

按产品分类，电子母婴监护仪预计在预测期内增长最快。 造成这种情况的主要原因是先天性异常的增加。

按移动性别划分，预计非便携式系统部分的复合年增长率最高。 非便携型市场占有率较高，因为医院推出了很多母婴健康管理应用。

按最终用户划分，医院所占份额最高且增长率最快。 该细分市场的增长可归因于出生和怀孕人数的增加以及政府对医院新设备的支持。

按地区划分，北美将在 2021 年占据最大份额。 另一方面，亚太地区预计增长最快。 该地区的产品批准和推出正在推动该地区的市场增长。

本报告分析了全球胎儿监护市场，包括市场的基本结构和最新发展、主要市场驱动因素和製约因素，以及按产品、手机性别、方法、最终用户和地区划分的市场。我们研究趋势前景，市场竞争状况，主要公司概况等。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 供应链分析
  • 价值链分析
  • 生态系统分析
  • 监管状况
  • 波特的五力分析
  • 胎儿监护产品专利分析
  • 贸易分析：超声波设备
  • 技术分析

第 6 章胎儿监护市场：按产品分类

  • 简介
  • 超声波设备
    • 二维超声
    • 3D/4D 超声
    • 多普勒图像
  • 电子母胎监护仪
  • 胎儿电极
  • 胎儿多普勒设备
  • 子宫收缩监测器
    • 内部子宫收缩监测器
    • 体外子宫收缩监测仪
  • 遥测设备
  • 配件和消耗品
  • 其他产品

第 7 章胎儿监护市场：便携式性别

  • 简介
  • 非便携式设备
  • 便携式设备

第 8 章胎儿监护市场：按方法分类

  • 简介
  • 非侵入性技术
  • 侵入性技术

第 9 章胎儿监护市场：按应用

  • 简介
  • 产前
  • 临产

第 10 章胎儿监护市场：最终用户

  • 简介
  • 医院
  • 妇产科诊所
  • 家庭护理

第 11 章胎儿监护市场：按地区

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太国家
  • 其他国家（行）
    • 拉丁美洲
    • 中东和非洲

第12章竞争格局

  • 概览
  • 主要公司/有影响力公司的战略
  • 主要公司的收入份额分析
  • 市场份额分析
  • 企业评估象限（2021 年）
  • 商业评估象限：适用于初创企业/中小企业（2021 年）
  • 竞争基准
  • 竞争场景
    • 产品发布
    • 资本交易
    • 其他趋势

第13章公司简介

  • 主要公司
    • GE HEALTHCARE
    • SIEMENS HEALTHINEERS
    • CARDINAL HEALTH, INC.
    • KONINKLIJKE PHILIPS N.V.
    • FUJIFILM SONOSITE, INC.
    • HUNTLEIGH HEALTHCARE LIMITED
    • NATUS MEDICAL INCORPORATED
    • THE COOPER COMPANIES, INC.
    • CONTEC MEDICAL SYSTEMS CO., LTD.
    • EDAN INSTRUMENTS, INC.
  • 其他企业
    • NEOVENTA MEDICAL AB
    • BIONET CO., LTD.
    • PROGETTI SRL
    • TRISMED CO., LTD.
    • SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
    • MEDGYN PRODUCTS, INC.
    • DIXION
    • PROMED TECHNOLOGY CO., LTD.
    • ADVANCED INSTRUMENTATIONS
    • BRAEL-MEDICAL EQUIPMENT
    • GPC MEDICAL LTD.
    • SHENZHEN VCOMIN TECHNOLOGY LIMITED
    • BISTOS CO., LTD.
    • MEDIANA CO., LTD.
    • LIFE PLUS HEALTHCARE (P) LTD.
    • CHOICEMMED
    • TRIVITRON HEALTHCARE
    • DOTT MEDICAL CO. LTD.
    • SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
    • NEMO HEALTHCARE
    • MINDCHILD MEDICAL, INC.
    • MELODY INTERNATIONAL LTD.
    • JANITRI INNOVATIONS PVT. LTD.
    • LAERDAL GLOBAL HEALTH

第14章 附录

简介目录
Product Code: MD 3253

The global fetal monitoring market is projected to reach USD 5.2 Billion by 2027 from USD 3.7 Billion in 2022, at a CAGR of 7.3% during the forecast period. Growth in this market is mainly driven by the technological advancements in fetal monitoring products, and the rise in number of gynecological clinics.

"The electronic maternal/fetal monitors accounted for the highest growth rate in the fetal monitoring market, by product, during the forecast period."

Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. The fastest-growing segment in this market during the forecast period is the fetal monitors. This segment's growth can primarily be attributed to the rising congenital anomalies.

"Non-portable systems segment accounted for the highest CAGR."

Based on portability, the market is segmented into non-portable systems and portable systems. In 2021, non-portable systems accounted for the largest share because it has more number of applications in hospitals for maternal and fetal well being.

"The hospitals accounted for the highest growth rate in the fetal monitoring market, by end user, during the forecast period."

The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2021, hospitals accounted for the largest share of this market. The growth of this segments can be attributed to the growing number of births and pregnancies, and initiatives by government for new tools and devices in hospitals.

"Asia Pacific: The fastest-growing region fetal monitoring market."

The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The presence of key players in the region and the better healthcare facilities are the major factors supporting the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as ongoing product approvals and launches in the region are factors driving the market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

Cardinal Health, Inc. (US)

Koninklijke Philips N.V. (Netherlands)

GE Healthcare (US)

Siemens Healthineers (Germany)

FUJIFILM SonoSite, Inc. (US)

Natus Medical Incorporated (US)

Huntleigh Healthcare Limited (UK)

The Cooper Companies Inc. (US)

CONTEC Medical Systems Co., Ltd. (China)

EDAN Instruments, Inc. (China)

Neoventa Medical AB (Sweden)

Bionet Co., Ltd. (South Korea)

Progetti Srl (Italy)

TRISMED Co., Ltd. (Republic of Korea)

ShenZhen Luckcome Technology Inc. (China)

MedGyn Products, Inc (US)

Dixion (Germany)

Promed Group Co., Ltd. (Hong Kong)

Advanced Instrumentations (US)

BRAEL-Medical Equipment (Poland)

GPC Medical (India)

BISTOS (Korea)

Mediana Co. Ltd (Korea)

Life Plus Medical (India)

ChoiceMMed (China)

Trivitron Healthcare (India)

Dott Medical Co. Ltd. (China)

Shenzhen Comen Medical Instruments Co., Ltd. (China)

Shenzhen Vcomin Technology Limited (China)

Nemo Healthcare (Netherlands)

MindChild Medical, Inc. (US)

Melody International Ltd. (Japan)

Janitri Innovations Pvt. Ltd. (India)

Laerdal Global Health (Norway)

Research Coverage:

This report provides a detailed picture of the global fetal monitoring market. It aims at estimating the size and future growth potential of the market across different segments, such as product, portability, method, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall fetal monitoring market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 2 USD EXCHANGE RATES
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
    • TABLE 3 KEY DATA FROM PRIMARY SOURCES
    • FIGURE 3 KEY INDUSTRY INSIGHTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
    • FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
      • 2.2.1.1 Growth forecast
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    • FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION)
    • FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION)
    • FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    • FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
    • FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET

4 PREMIUM INSIGHTS

  • 4.1 FETAL MONITORING MARKET OVERVIEW
    • FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET
  • 4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021)
    • FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021
  • 4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET
    • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 FETAL MONITORING MARKET: REGIONAL MIX
    • FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
  • 4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
    • FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 FETAL MONITORING MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment
      • 5.2.1.2 Advanced and innovative fetal monitoring technologies
      • 5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
      • 5.2.1.4 Reimbursement and insurance policies for fetal monitoring services
    • TABLE 4 CPT CODES FOR VAGINAL DELIVERIES
      • 5.2.1.5 Active product launches by key manufacturers
      • 5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs of fetal monitoring equipment
      • 5.2.2.2 Availability of refurbished products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors
      • 5.2.3.2 Emerging markets and strengthening infrastructure
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Product recalls
    • TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET
      • 5.2.4.2 Lack of skilled healthcare professionals
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 DIRECT DISTRIBUTION - PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS
    • 5.5.1 ROLE IN ECOSYSTEM
    • FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM
  • 5.6 REGULATORY LANDSCAPE
    • TABLE 6 REGULATORY AUTHORITIES
    • 5.6.1 EU REGULATIONS
    • 5.6.2 US REGULATIONS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT FROM NEW ENTRANTS
    • 5.7.2 BARGAINING POWER OF SUPPLIERS
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.5 THREAT OF SUBSTITUTES
  • 5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS
    • FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS (2013-NOVEMBER 2022)
    • FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013-NOVEMBER 2022)
    • FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013-NOVEMBER 2022)
  • 5.9 TRADE ANALYSIS FOR ULTRASOUND
    • 5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017-2021 (USD MILLION)
    • 5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017-2021 (USD MILLION)
  • 5.10 TECHNOLOGY ANALYSIS
    • TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS

6 FETAL MONITORING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 ULTRASOUND DEVICES
    • TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.1 2D ULTRASOUND
      • 6.2.1.1 Increasing commercialization of innovative 2D technologies
    • TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.2 3D & 4D ULTRASOUND
      • 6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound
    • TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.3 DOPPLER IMAGING
      • 6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance
    • TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 ELECTRONIC MATERNAL/FETAL MONITORS
    • 6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES
    • TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 FETAL ELECTRODES
    • 6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE
    • TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.5 FETAL DOPPLER DEVICES
    • 6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS
    • TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.6 UTERINE CONTRACTION MONITORS
    • TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
      • 6.6.1.1 Accurate measurements obtained by internal UCMs
    • TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
      • 6.6.2.1 Developments underway to overcome drawbacks of external UCMs
    • TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.7 TELEMETRY DEVICES
    • 6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES
    • TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.8 ACCESSORIES & CONSUMABLES
    • 6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES
    • TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.9 OTHER PRODUCTS
    • TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)

7 FETAL MONITORING MARKET, BY PORTABILITY

  • 7.1 INTRODUCTION
    • TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
  • 7.2 NON-PORTABLE SYSTEMS
    • 7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
    • TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 PORTABLE SYSTEMS
    • 7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH
    • TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)

8 FETAL MONITORING MARKET, BY METHOD

  • 8.1 INTRODUCTION
    • TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
  • 8.2 NON-INVASIVE METHOD
    • 8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES
    • TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 INVASIVE METHOD
    • 8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS
    • TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)

9 FETAL MONITORING MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.2 ANTEPARTUM
    • 9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH
    • TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 INTRAPARTUM
    • 9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH
    • TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)

10 FETAL MONITORING MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.2 HOSPITALS
    • 10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
    • TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.3 OBSTETRICS & GYNECOLOGY CLINICS
    • 10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT
    • TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.4 HOME CARE SETTINGS
    • 10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH
    • TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)

11 FETAL MONITORING MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
    • TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.2.1 RECESSION IMPACT
    • 11.2.2 US
      • 11.2.2.1 US held largest share of North American market in 2021
    • FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018-2020 (AVERAGE)
    • TABLE 46 ULTRASOUND CPT CODES
    • TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 53 US: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada
    • FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021
    • TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.3 EUROPE
    • TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.1 RECESSION IMPACT
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing healthcare expenditure to support market growth in Germany
    • TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK
    • TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France
    • TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011-2019
    • TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy
    • TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Declining birth rate to restrain growth of market in Spain
    • TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
    • 11.4.1 RECESSION IMPACT
    • TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan
    • TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Developing healthcare infrastructure in China to support market growth
    • TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Growing number of preterm births to drive market growth in India
    • TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea
    • TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia
    • TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • 11.5.1 RECESSION IMPACT
    • TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.5.2 LATIN AMERICA
      • 11.5.2.1 Favorable government policies to support growth of market
    • TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 11.5.3 MIDDLE EAST & AFRICA
      • 11.5.3.1 High number of pre-term births recorded to boost market
    • TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020-2027 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD, 2020-2027 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
  • 12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
  • 12.5 COMPANY EVALUATION QUADRANT (2021)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021
  • 12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 STARTING BLOCKS
    • 12.6.3 RESPONSIVE COMPANIES
    • 12.6.4 DYNAMIC COMPANIES
    • FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021
  • 12.7 COMPETITIVE BENCHMARKING
    • TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS
    • TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 188 PRODUCT LAUNCHES, 2019-NOVEMBER 2022
    • 12.8.2 DEALS
    • TABLE 189 DEALS, 2019-NOVEMBER 2022
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 190 OTHER DEVELOPMENTS, 2019-NOVEMBER 2022

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *

  • 13.1 KEY PLAYERS
    • 13.1.1 GE HEALTHCARE
    • TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
    • TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED
    • TABLE 193 GE HEALTHCARE: DEALS
    • 13.1.2 SIEMENS HEALTHINEERS
    • TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
    • TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
    • TABLE 196 SIEMENS HEALTHINEERS: DEALS
    • 13.1.3 CARDINAL HEALTH, INC.
    • TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
    • TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
    • 13.1.4 KONINKLIJKE PHILIPS N.V.
    • TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
    • TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
    • TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
    • 13.1.5 FUJIFILM SONOSITE, INC.
    • TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
    • FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
    • TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED
    • TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES
    • TABLE 205 FUJIFILM SONOSITE, INC.: DEALS
    • 13.1.6 HUNTLEIGH HEALTHCARE LIMITED
    • TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
    • FIGURE 43 ARJO: COMPANY SNAPSHOT
    • TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED
    • 13.1.7 NATUS MEDICAL INCORPORATED
    • TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
    • TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
    • TABLE 210 NATUS MEDICAL INCORPORATED: DEALS
    • 13.1.8 THE COOPER COMPANIES, INC.
    • TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
    • FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT
    • TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
    • TABLE 213 THE COOPER COMPANIES, INC.: DEALS
    • 13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
    • TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
    • TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
    • TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES
    • TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS
    • 13.1.10 EDAN INSTRUMENTS, INC.
    • TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW
    • TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED
    • TABLE 220 EDAN INSTRUMENTS, INC.: DEALS
    • TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS
  • 13.2 OTHER PLAYERS
    • 13.2.1 NEOVENTA MEDICAL AB
    • 13.2.2 BIONET CO., LTD.
    • 13.2.3 PROGETTI SRL
    • 13.2.4 TRISMED CO., LTD.
    • 13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
    • 13.2.6 MEDGYN PRODUCTS, INC.
    • 13.2.7 DIXION
    • 13.2.8 PROMED TECHNOLOGY CO., LTD.
    • 13.2.9 ADVANCED INSTRUMENTATIONS
    • 13.2.10 BRAEL-MEDICAL EQUIPMENT
    • 13.2.11 GPC MEDICAL LTD.
    • 13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED
    • 13.2.13 BISTOS CO., LTD.
    • 13.2.14 MEDIANA CO., LTD.
    • 13.2.15 LIFE PLUS HEALTHCARE (P) LTD.
    • 13.2.16 CHOICEMMED
    • 13.2.17 TRIVITRON HEALTHCARE
    • 13.2.18 DOTT MEDICAL CO. LTD.
    • 13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
    • 13.2.20 NEMO HEALTHCARE
    • 13.2.21 MINDCHILD MEDICAL, INC.
    • 13.2.22 MELODY INTERNATIONAL LTD.
    • 13.2.23 JANITRI INNOVATIONS PVT. LTD.
    • 13.2.24 LAERDAL GLOBAL HEALTH

Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INDUSTRY INSIGHTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 CUSTOMIZATION OPTIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS